Soterix Medical, Inc HD-IFS PRO 8 Channel Stimulator Purchase for HPSNS Lab

General Information

Document Type:

Presolicitation

Synopsis Number:

75N98026Q00914

Posted Date:

July 30, 2026

Original Response Date:

August 10, 2026

Current Response Date:

August 10, 2026

Set Aside:

N/A

NAICS Code:

541715

Contracting Office Address

National Institutes of Health (NIH), Office of the Director (OD)

Office of Logistics and Operations (OLAO)

Office of Acquisition and Logistics Management (OALM)

Hospital and Laboratory Support Division

6701 Rockledge Drive

Bethesda, MD 20817 

Description

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:

Soterix Medical, Inc

Aspen Corporate Park

1480 US Highway 9 North, 204

Woodbridge, NJ 07095

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 541715 with a Size Standard $1000.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

GENERAL INFORMATION

1. Title: Soterix Medical, Inc HD-IFS PRO 8 Channel Stimulator Purchase for HPSNS Lab
2. Background Information: Our overall program objective is to perform translational human subjects research that leads to the development of new therapeutic technologies for the rehabilitation of motor skill function following brain injury or stroke. Our previous work, as well as the work of other research groups in our field, has indicated that non-invasive stimulation of deeper brain structures such as the basal ganglia or hippocampus can facilitate learning of new motor skills and rehabilitation outcomes in stroke patients. This TIS system, will provide for the the first time, a new capability within the lab to target and modulate these deep brain structures with non-invasive brain stimulation.

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by August 10, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00914. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”